<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) have been associated with different diseases </plain></SENT>
<SENT sid="1" pm="."><plain>They are defined as a large family of immunoglobulins (Ig) of either alloantibodies or autoantibodies </plain></SENT>
<SENT sid="2" pm="."><plain>The autoimmune antibodies are associated with venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and recurrent fetal loss in the so-called <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> or in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>These antibodies are directed against proteins or <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-protein complexes </plain></SENT>
<SENT sid="4" pm="."><plain>On the contrary, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (alloantibodies) which are found in <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> sera (<z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e>, HIV, and other <z:mp ids='MP_0001799'>viral</z:mp> diseases), disappear with illness remission and are directed to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> alone (particularly <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>) and are not associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> or recurrent fetal loss </plain></SENT>
<SENT sid="5" pm="."><plain>However, the role and type of aPL found during <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatic diseases</z:e> is still unclear </plain></SENT>
<SENT sid="6" pm="."><plain>To investigate the prevalence of autoimmune aPL (IgG and IgM) during different <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatic diseases</z:e>, we have studied 128 patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus and hepatic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> without treatment as well as 40 healthy control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>We have used a specific ELISA kit, that uses a mixture of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> instead of <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> alone, and allows a better detection of aPL of the autoimmune type </plain></SENT>
<SENT sid="8" pm="."><plain>Our results show that autoimmune aPL are not significantly increased in <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatic diseases</z:e> (2%) or <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> of the liver (3%) when compared to the control group (0%) </plain></SENT>
</text></document>